| Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ... Annals of oncology 24 (9), 2206-2223, 2013 | 4643 | 2013 |
| Tailoring Therapies - Improving the Management of Early Breast Cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2016 PM Coates AS, Winer EP, Goldhirsch A, Gelber RD, Gnant M, Piccart-Genhart M ... Annals of Oncology 26 (8), 1533-1546, 2015 | 2378 | 2015 |
| De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 G Curigliano, HJ Burstein, EP Winer, M Gnant, P Dubsky, S Loibl, ... Annals of Oncology 28 (8), 1700-1712, 2017 | 1338 | 2017 |
| The effect of group psychosocial support on survival in metastatic breast cancer PJ Goodwin, M Leszcz, M Ennis, J Koopmans, L Vincent, H Guther, ... New England Journal of Medicine 345 (24), 1719-1726, 2001 | 1309 | 2001 |
| Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study PJ Goodwin, M Ennis, KI Pritchard, ME Trudeau, J Koo, Y Madarnas, ... Journal of clinical oncology 20 (1), 42-51, 2002 | 1159 | 2002 |
| Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis A DeCensi, M Puntoni, P Goodwin, M Cazzaniga, A Gennari, B Bonanni, ... Cancer prevention research 3 (11), 1451-1461, 2010 | 1087 | 2010 |
| Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials B Asselain, W Barlow, J Bartlett, J Bergh, E Bergsten-Nordström, J Bliss, ... The Lancet Oncology 19 (1), 27-39, 2018 | 1028 | 2018 |
| Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer M Levine, J Hirsh, A Arnold, M Gent, V Bramwell, KI Pritchard, D Stewart, ... The Lancet 343 (8902), 886-889, 1994 | 712 | 1994 |
| Risk of menopause during the first year after breast cancer diagnosis PJ Goodwin, M Ennis, KI Pritchard, M Trudeau, N Hood Journal of Clinical Oncology 17 (8), 2365-2365, 1999 | 678 | 1999 |
| Understanding the benefit of metformin use in cancer treatment RJO Dowling, PJ Goodwin, V Stambolic BMC medicine 9, 1-6, 2011 | 552 | 2011 |
| Prognostic factors in osteosarcoma: a critical review. AM Davis, RS Bell, PJ Goodwin Journal of Clinical Oncology 12 (2), 423-431, 1994 | 515 | 1994 |
| Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer E Warner, W Foulkes, P Goodwin, W Meschino, J Blondal, C Paterson, ... Journal of the National Cancer Institute 91 (14), 1241-1247, 1999 | 511 | 1999 |
| Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer PJ Goodwin, M Ennis, KI Pritchard, J Koo, N Hood Journal of Clinical Oncology 27 (23), 3757-3763, 2009 | 457 | 2009 |
| Metformin in cancer: translational challenges. RJ Dowling, S Niraula, V Stambolic, PJ Goodwin Journal of molecular endocrinology 48 (3), R31-43, 2012 | 435 | 2012 |
| Obesity and breast cancer prognosis: evidence, challenges, and opportunities S Jiralerspong, PJ Goodwin Journal of Clinical Oncology 34 (35), 4203-4216, 2016 | 424 | 2016 |
| Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis PJ Goodwin, M Ennis, KI Pritchard, D McCready, J Koo, S Sidlofsky, ... Journal of Clinical Oncology 17 (1), 120-120, 1999 | 410 | 1999 |
| Insulin and related factors in premenopausal breast cancer risk ME Del Giudice, IG Fantus, S Ezzat, G McKeown-Eyssen, D Page, ... Breast cancer research and treatment 47, 111-120, 1998 | 386 | 1998 |
| Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer … R Gray, R Bradley, J Braybrooke, Z Liu, R Peto, L Davies, D Dodwell, ... The lancet 393 (10179), 1440-1452, 2019 | 366 | 2019 |
| Second malignant neoplasms: assessment and strategies for risk reduction ME Wood, V Vogel, A Ng, L Foxhall, P Goodwin, LB Travis Journal of clinical oncology 30 (30), 3734-3745, 2012 | 358 | 2012 |
| The role of obesity in cancer survival and recurrence W Demark-Wahnefried, EA Platz, JA Ligibel, CK Blair, KS Courneya, ... Cancer Epidemiology, Biomarkers & Prevention 21 (8), 1244-1259, 2012 | 338 | 2012 |
Kathleen I. PritchardProfessor, Division of Medical Oncology, University of Torontoยืนยันอีเมลแล้วที่ sunnybrook.ca
